In a regulatory filing, Precigen disclosed that its director Fred Hassan bought 570K shares of common stock on August 14th in a total transaction size of $998K.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PGEN:
- Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025
- Precigen reports Q2 ContOps EPS (8c), consensus (10c)
- Precigen announces agreement with FDA for Phase 1/2 study of PRGN-2012
- PGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Precigen receives FDA Breakthrough Therapy Designation for PRGN-2012